Edgewell Personal Care (EPC) FCF Margin (2009 - 2026)
Edgewell Personal Care's (EPC) quarterly FCF Margin came in at 18.08% in Q2 2026, up 37.0% year-over-year from 13.2% in Q2 2025, and up 133.12% quarter-over-quarter from 7.76% in Q1 2026.
Analysis
Edgewell Personal Care (EPC) FCF Margin (2009 - 2026) Analysis & Trends
Edgewell Personal Care (EPC) has reported FCF Margin for 18 consecutive years, with 18.08% the latest figure, recorded in Q2 2026.
- On a quarterly basis, FCF Margin rose 37.0% year-over-year to 18.08% in Q2 2026; TTM through Jun 2026 was 2.34%, a 2320.0% increase from a year earlier, with the FY2025 full-year figure at 1.86%, up 1462.0% from the prior year.
- FCF Margin was 18.08% for Q2 2026 at Edgewell Personal Care, up from 7.76% in the prior quarter.
- Over five years, FCF Margin peaked at 23.71% in Q2 2023 and troughed at 80.02% in Q3 2024.
- A 5-year average of 6.05% and a median of 5.89% in 2025 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin sank 7739 bps in 2023 and soared 8638 bps in 2025, its largest moves.
- Over 5 years, FCF Margin stood at 20.81% in 2022, then gained by 22 bps to 16.24% in 2023, then tumbled by 96 bps to 31.9% in 2024, then fell by 2 bps to 32.52% in 2025, then soared by 156 bps to 18.08% in 2026.
- The last three FCF Margin figures came in at 18.08% (Q2 2026), 7.76% (Q1 2026), and 32.52% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.53 Bn | 69.16 Bn | 3.30 Bn | 16.17% |
| 2 | Kenvue | 34.61 Bn | 33.50 Bn | 2.30 Bn | 15.78% |
| 3 | Kimberly Clark | 33.35 Bn | 32.40 Bn | 1.60 Bn | 13.27% |
| 4 | Bath & Body Works | 4.00 Bn | 3.20 Bn | 692.00 Mn | - |
| 5 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | - | - |
| 6 | Perrigo | 2.01 Bn | 1.61 Bn | 313.90 Mn | 6.68% |
| 7 | Herbalife | 1.27 Bn | 903.35 Mn | 1.03 Bn | 1.63% |
| 8 | Edgewell Personal Care | 1.27 Bn | 869.73 Mn | 242.50 Mn | 18.08% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 622.88 Mn | 516.98 Mn | 40.36 Mn | 37.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.08% |
| Mar 31, 2026 | 7.76% |
| Dec 31, 2025 | -32.52% |
| Sep 30, 2025 | 6.36% |
| Jun 30, 2025 | 17.72% |
| Mar 31, 2025 | 5.42% |
| Dec 31, 2024 | -31.90% |
| Sep 30, 2024 | -80.02% |
| Jun 30, 2024 | 13.68% |
| Mar 31, 2024 | 19.60% |
| Dec 31, 2023 | -16.24% |
| Sep 30, 2023 | -75.42% |
| Jun 30, 2023 | 23.71% |
| Mar 31, 2023 | 13.49% |
| Dec 31, 2022 | -20.81% |
| Sep 30, 2022 | 1.97% |
| Jun 30, 2022 | 16.01% |
| Mar 31, 2022 | 4.29% |
| Dec 31, 2021 | -19.08% |
| Sep 30, 2021 | 9.28% |